Biopharmaceutics has become a new round of competition focus. China's industrial clusters are constantly forming

[editor's view of China Pharmaceutical network] biopharmaceutical industry is the focus of the development of pharmaceutical industry in the world today In 2015, the world's top 10 drugs, 8 of which are biological products, with a total sales volume of 64.3 billion US dollars The development of the world's biopharmaceutical industry enlightens us that biopharmaceutical industry will become the focus of a new round of competition and development in China's pharmaceutical industry To seize the biomedical market, many places in our country are starting to take action, and the biomedical industry cluster is constantly forming Biomedicine has become a new round of competition focus China's industrial clusters are constantly forming in Tianjin to cultivate biomedical industrial clusters In the next few years, Tianjin will focus on making good use of the advantages of the development and opening of Binhai New Area and the coordinated development of Beijing, Tianjin and Hebei to cultivate and form six biomedical industry innovation and development clusters in Binhai New Area, biomedical industry R & D and transformation clusters in the west of Tianjin Development Zone, Tianjin Health Industrial Park, Wuqing medical and Health Industrial Park, Beichen modern Chinese medicine industrial park, Xiqing modern medicine industrial park, etc The biomedical industry cluster with influence at home and abroad will form an industrial scale of 220 billion yuan by 2020 In recent years, Taizhou China Pharmaceutical city has made great efforts to build a gathering place In recent years, Taizhou China Pharmaceutical city has carefully analyzed and accurately grasped the new development trend of domestic and foreign pharmaceutical industry, and put the development of bio pharmaceutical industry in a prominent position Since this year, the biomedical industry in China's pharmaceutical city has accelerated its agglomeration, and the application of biological products has soared all the way In the first nine months, Jiangsu food and Drug Administration accepted 60% of the biological products of China Pharmaceutical city Chengdu to build Tianfu international biological city Chengdu Tianfu international biological city is an industrial new city jointly built by Chengdu high tech Zone and Shuangliu district It will focus on the development of biomedicine, biomedical engineering, biological services, intelligent health and other industrial fields In the future, it will be built into a world-famous habitat for innovative talents in biological industry, a capital of innovation and intelligent manufacturing in biological industry, and a life and health town with international influence Up to now, Chengdu Tianfu international biological city has 180 projects in storage, including 33 signed projects and 13 to be signed There are 2 Nobel Prize teams, 1 academician team of the Chinese Academy of Sciences and the Chinese Academy of Sciences, 4 national teams, and 9 high-level talent teams returning from overseas Guangdong builds bio pharmaceutical enterprise ecosystem Guangzhou Development Zone, as the national biological industry base of Guangzhou and the pilot area of individualized medical and biomedical innovative industry cluster of the Ministry of science and technology, has gathered and cultivated a group of enterprising and innovative leading enterprises in the subdivision field, forming a biomedical and health industry with health food, medical equipment and modern Chinese medicine as the leading force and medical treatment as the new power System In the next stage, Guangzhou Development Zone will further improve the development policy of biomedicine and health industry, focus on supporting core technology research, and strive to promote the transformation and industrialization of major scientific research achievements We will make full use of the platform of the Pearl River Delta independent innovation demonstration zone, vigorously promote the pilot reform of the drug listing license holder system, further expand the scope of the pilot biological material inspection and quarantine supervision, and explore the establishment of a platform for centralized and rapid clearance of biological samples At the same time, pharmaceutical enterprises are encouraged to carry out cross-border integration of bio industry supported by Internet, cloud computing and big data technology, build a bio pharmaceutical large enterprise ecosystem, and promote the formation of advantageous industrial clusters in relevant subdivisions The development zone will strive to build a hundred billion level health industry and form a biomedical innovation center, medical industry zone and health service demonstration zone with certain influence at home and abroad Beijing launched the third phase of the "G20 project" for biomedical industry At present, Beijing's biomedical industry has formed an overall scientific and technological layout integrating the frontier technology of life science and health medicine, biomedical industry and clinical medicine research Guided by clinical needs and supported by cutting-edge technologies, we will build and improve the innovation system of Beijing's biomedical industry The development of biomedical industry is in line with Beijing's development orientation of building a national science and technology innovation center, and meets the requirements of Beijing's industrial upgrading, structural optimization and green development During the 13th Five Year Plan period, through the implementation of the third phase of the G20 project, the scale of Beijing's biomedical industry will reach 180 billion yuan, and the profit margin of the pharmaceutical industry will continue to be maintained nationwide; more than 10 innovative enterprises with international advanced technology level will be cultivated; a number of innovative new drugs and medical devices with independent intellectual property rights will be accelerated to be cultivated; We will strengthen research and development of major new drugs, support innovation in biopharmaceutical, chemical and traditional Chinese medicine, accelerate preclinical research, clinical research and production process research, support large varieties of international clinical research, expand overseas markets, and accelerate the transformation and application of domestic new drugs During the 13th Five Year Plan period of building a 50 billion level biomedical industry in Hangzhou Economic and Technological Development Zone, Hangzhou Development Zone will take the construction of the Eastern medicine port town as the carrier, and make every effort to build an ecological system of the whole biomedical industry chain The person in charge of the Management Committee of the Development Zone said that through three to five years of development, we will strive to achieve "three multipliers" of biomedical talent projects, scientific and technological achievements, and performance contributions, with an output value of 50 billion yuan, and strive to build a domestic technology pilot area, innovation and entrepreneurship team and talent gathering area, and the primary bearing area for global advanced pharmaceutical technology to enter China Conclusion: biomedical industry is one of the seven strategic emerging industries in China It has great practical and economic significance to develop biomedical industry in China On the one hand, China has entered an aging society, with a population of more than 120 million over the age of 65 The rapid growth of medical demand will put forward new requirements for the future development of China's biomedical industry On the other hand, China's independent drug research and development is still very weak Drug production is mainly based on imitation, and there are few original drugs There is a big gap between the key technologies of biomedicine and the international level Cultivating and developing the biomedical industry and promoting the whole industry to participate in international competition will be the key to improve the overall development level and competitiveness of China's biomedical industry With the continuous formation and development of China's biopharmaceutical industry cluster, China's biopharmaceutical development will also take a new step.